• Medientyp: E-Artikel
  • Titel: The relationship between bone mass and body composition in children with hypothalamic and simple obesity
  • Beteiligte: Shaikh, M. Guftar; Crabtree, Nicola; Kirk, Jeremy M. W.; Shaw, Nicholas J.
  • Erschienen: Wiley, 2014
  • Erschienen in: Clinical Endocrinology
  • Sprache: Englisch
  • DOI: 10.1111/cen.12263
  • ISSN: 0300-0664; 1365-2265
  • Schlagwörter: Endocrinology, Diabetes and Metabolism ; Endocrinology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Summary</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Obesity has been associated with a positive influence on bone mass. This is thought to be due to a mechanical load exerted on the skeleton, together with various hormones and adipocytokines that control appetite and weight, such as leptin, some of which directly affect bone mass. However, there are conflicting reports of the association between fat mass and bone mass in children. Animal studies demonstrate increased bone mass where there is impaired central leptin signalling. Hypothalamic damage can cause abnormal central leptin action, which contributes to the development of obesity.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>The objective of this study was to investigate the relationship between body composition and bone mass in hypothalamic and simple childhood obesity, in conjunction with the effect of the adipocytokines, leptin and adiponectin.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>This was a cross‐sectional study of three groups of children, those with hypothalamic obesity (<jats:styled-content style="fixed-case">HO</jats:styled-content>), those with congenital hypopituitarism (<jats:styled-content style="fixed-case">CH</jats:styled-content>) and those with simple obesity (<jats:styled-content style="fixed-case">SO</jats:styled-content>).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A total of 65 children (<jats:styled-content style="fixed-case">HO</jats:styled-content> = 26 [11 males], <jats:styled-content style="fixed-case">CH</jats:styled-content> = 17 [eight males] and <jats:styled-content style="fixed-case">SO</jats:styled-content> = 22 [15 males]) had body composition assessed using dual‐energy X‐ray absorptiometry together with measurement of serum leptin and adiponectin. No significant differences were seen in bone mass once bone density (<jats:styled-content style="fixed-case">BMD</jats:styled-content>) was adjusted for differences in body size between groups. Significantly elevated levels of leptin and adiponectin were seen in the <jats:styled-content style="fixed-case">HO</jats:styled-content> group compared with the <jats:styled-content style="fixed-case">SO</jats:styled-content> group (<jats:italic>P</jats:italic> &lt; 0·01, <jats:italic>P</jats:italic> &lt; 0·05, respectively).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Adiposity is associated with increased bone mass; however, this relationship is complex. Despite the presence of hyperleptinaemia, increased bone mass in the <jats:styled-content style="fixed-case">HO</jats:styled-content> group was not seen. This may be due to the effects of other factors such as adiponectin, abnormal hypothalamic signalling, pituitary hormone deficiencies and disruption of normal homoeostatic mechanisms within the hypothalamus.</jats:p></jats:sec>